The present invention provides pharmaceutical compositions and methods for prevention or treatment of autoimmune diseases and other T cell mediated inflammatory diseases and conditions, which comprise as an active ingredient an effective quantity of a peptide derived from HIV gp41 fusion peptide domain or fragments, analogs, homologs and derivatives thereof. The invention further provides novel peptides derived from HIV gp41 fusion peptide domain, useful in the treatment of T cell mediated pathologies.
申请公布号
WO2006077601(A3)
申请公布日期
2006.11.23
申请号
WO2006IL00096
申请日期
2006.01.24
申请人
YEDA RESEARCH & DEVELOPMENT CO. LTD.;SHAI, YECHIEL;COHEN, IRUN, R.;QUINTANA, FRANCISCO, J.;GERBER, DORON